Lysosomal Alpha Glucosidase Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281437 No. of Pages: 72 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Lysosomal Alpha Glucosidase in global, including the following market information:
Global Lysosomal Alpha Glucosidase Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lysosomal Alpha Glucosidase Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Lysosomal Alpha Glucosidase companies in 2021 (%)
The global Lysosomal Alpha Glucosidase market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
AT-982 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lysosomal Alpha Glucosidase include Amicus Therapeutics Inc, Audentes Therapeutics Inc, Etubics Corp, Genzyme Corp, greenovation Biotech GmbH, Huons Co Ltd, JCR Pharmaceuticals Co Ltd, Oxyrane Belgium NV and Pharming Group NV and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lysosomal Alpha Glucosidase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lysosomal Alpha Glucosidase Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Lysosomal Alpha Glucosidase Market Segment Percentages, by Type, 2021 (%)
AT-982
ATB-200
AVRRD-03
JR-162
MOSS-GAA
OXY-2810
Others
Global Lysosomal Alpha Glucosidase Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Lysosomal Alpha Glucosidase Market Segment Percentages, by Application, 2021 (%)
Glycogen Storage Disease
Pompe Disease
Others
Global Lysosomal Alpha Glucosidase Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Lysosomal Alpha Glucosidase Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lysosomal Alpha Glucosidase revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lysosomal Alpha Glucosidase revenues share in global market, 2021 (%)
Key companies Lysosomal Alpha Glucosidase sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Lysosomal Alpha Glucosidase sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amicus Therapeutics Inc
Audentes Therapeutics Inc
Etubics Corp
Genzyme Corp
greenovation Biotech GmbH
Huons Co Ltd
JCR Pharmaceuticals Co Ltd
Oxyrane Belgium NV
Pharming Group NV
Sarepta Therapeutics Inc
1 Introduction to Research & Analysis Reports
1.1 Lysosomal Alpha Glucosidase Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lysosomal Alpha Glucosidase Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lysosomal Alpha Glucosidase Overall Market Size
2.1 Global Lysosomal Alpha Glucosidase Market Size: 2021 VS 2028
2.2 Global Lysosomal Alpha Glucosidase Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Lysosomal Alpha Glucosidase Sales: 2017-2028
3 Company Landscape
3.1 Top Lysosomal Alpha Glucosidase Players in Global Market
3.2 Top Global Lysosomal Alpha Glucosidase Companies Ranked by Revenue
3.3 Global Lysosomal Alpha Glucosidase Revenue by Companies
3.4 Global Lysosomal Alpha Glucosidase Sales by Companies
3.5 Global Lysosomal Alpha Glucosidase Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Lysosomal Alpha Glucosidase Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Lysosomal Alpha Glucosidase Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lysosomal Alpha Glucosidase Players in Global Market
3.8.1 List of Global Tier 1 Lysosomal Alpha Glucosidase Companies
3.8.2 List of Global Tier 2 and Tier 3 Lysosomal Alpha Glucosidase Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Lysosomal Alpha Glucosidase Market Size Markets, 2021 & 2028
4.1.2 AT-982
4.1.3 ATB-200
4.1.4 AVRRD-03
4.1.5 JR-162
4.1.6 MOSS-GAA
4.1.7 OXY-2810
4.1.8 Others
4.2 By Type - Global Lysosomal Alpha Glucosidase Revenue & Forecasts
4.2.1 By Type - Global Lysosomal Alpha Glucosidase Revenue, 2017-2022
4.2.2 By Type - Global Lysosomal Alpha Glucosidase Revenue, 2023-2028
4.2.3 By Type - Global Lysosomal Alpha Glucosidase Revenue Market Share, 2017-2028
4.3 By Type - Global Lysosomal Alpha Glucosidase Sales & Forecasts
4.3.1 By Type - Global Lysosomal Alpha Glucosidase Sales, 2017-2022
4.3.2 By Type - Global Lysosomal Alpha Glucosidase Sales, 2023-2028
4.3.3 By Type - Global Lysosomal Alpha Glucosidase Sales Market Share, 2017-2028
4.4 By Type - Global Lysosomal Alpha Glucosidase Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Lysosomal Alpha Glucosidase Market Size, 2021 & 2028
5.1.2 Glycogen Storage Disease
5.1.3 Pompe Disease
5.1.4 Others
5.2 By Application - Global Lysosomal Alpha Glucosidase Revenue & Forecasts
5.2.1 By Application - Global Lysosomal Alpha Glucosidase Revenue, 2017-2022
5.2.2 By Application - Global Lysosomal Alpha Glucosidase Revenue, 2023-2028
5.2.3 By Application - Global Lysosomal Alpha Glucosidase Revenue Market Share, 2017-2028
5.3 By Application - Global Lysosomal Alpha Glucosidase Sales & Forecasts
5.3.1 By Application - Global Lysosomal Alpha Glucosidase Sales, 2017-2022
5.3.2 By Application - Global Lysosomal Alpha Glucosidase Sales, 2023-2028
5.3.3 By Application - Global Lysosomal Alpha Glucosidase Sales Market Share, 2017-2028
5.4 By Application - Global Lysosomal Alpha Glucosidase Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Lysosomal Alpha Glucosidase Market Size, 2021 & 2028
6.2 By Region - Global Lysosomal Alpha Glucosidase Revenue & Forecasts
6.2.1 By Region - Global Lysosomal Alpha Glucosidase Revenue, 2017-2022
6.2.2 By Region - Global Lysosomal Alpha Glucosidase Revenue, 2023-2028
6.2.3 By Region - Global Lysosomal Alpha Glucosidase Revenue Market Share, 2017-2028
6.3 By Region - Global Lysosomal Alpha Glucosidase Sales & Forecasts
6.3.1 By Region - Global Lysosomal Alpha Glucosidase Sales, 2017-2022
6.3.2 By Region - Global Lysosomal Alpha Glucosidase Sales, 2023-2028
6.3.3 By Region - Global Lysosomal Alpha Glucosidase Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Lysosomal Alpha Glucosidase Revenue, 2017-2028
6.4.2 By Country - North America Lysosomal Alpha Glucosidase Sales, 2017-2028
6.4.3 US Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.4.4 Canada Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.4.5 Mexico Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Lysosomal Alpha Glucosidase Revenue, 2017-2028
6.5.2 By Country - Europe Lysosomal Alpha Glucosidase Sales, 2017-2028
6.5.3 Germany Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.5.4 France Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.5.5 U.K. Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.5.6 Italy Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.5.7 Russia Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.5.8 Nordic Countries Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.5.9 Benelux Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Lysosomal Alpha Glucosidase Revenue, 2017-2028
6.6.2 By Region - Asia Lysosomal Alpha Glucosidase Sales, 2017-2028
6.6.3 China Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.6.4 Japan Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.6.5 South Korea Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.6.6 Southeast Asia Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.6.7 India Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Lysosomal Alpha Glucosidase Revenue, 2017-2028
6.7.2 By Country - South America Lysosomal Alpha Glucosidase Sales, 2017-2028
6.7.3 Brazil Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.7.4 Argentina Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Lysosomal Alpha Glucosidase Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Lysosomal Alpha Glucosidase Sales, 2017-2028
6.8.3 Turkey Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.8.4 Israel Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.8.5 Saudi Arabia Lysosomal Alpha Glucosidase Market Size, 2017-2028
6.8.6 UAE Lysosomal Alpha Glucosidase Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Amicus Therapeutics Inc
7.1.1 Amicus Therapeutics Inc Corporate Summary
7.1.2 Amicus Therapeutics Inc Business Overview
7.1.3 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Major Product Offerings
7.1.4 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales and Revenue in Global (2017-2022)
7.1.5 Amicus Therapeutics Inc Key News
7.2 Audentes Therapeutics Inc
7.2.1 Audentes Therapeutics Inc Corporate Summary
7.2.2 Audentes Therapeutics Inc Business Overview
7.2.3 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Major Product Offerings
7.2.4 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales and Revenue in Global (2017-2022)
7.2.5 Audentes Therapeutics Inc Key News
7.3 Etubics Corp
7.3.1 Etubics Corp Corporate Summary
7.3.2 Etubics Corp Business Overview
7.3.3 Etubics Corp Lysosomal Alpha Glucosidase Major Product Offerings
7.3.4 Etubics Corp Lysosomal Alpha Glucosidase Sales and Revenue in Global (2017-2022)
7.3.5 Etubics Corp Key News
7.4 Genzyme Corp
7.4.1 Genzyme Corp Corporate Summary
7.4.2 Genzyme Corp Business Overview
7.4.3 Genzyme Corp Lysosomal Alpha Glucosidase Major Product Offerings
7.4.4 Genzyme Corp Lysosomal Alpha Glucosidase Sales and Revenue in Global (2017-2022)
7.4.5 Genzyme Corp Key News
7.5 greenovation Biotech GmbH
7.5.1 greenovation Biotech GmbH Corporate Summary
7.5.2 greenovation Biotech GmbH Business Overview
7.5.3 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Major Product Offerings
7.5.4 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales and Revenue in Global (2017-2022)
7.5.5 greenovation Biotech GmbH Key News
7.6 Huons Co Ltd
7.6.1 Huons Co Ltd Corporate Summary
7.6.2 Huons Co Ltd Business Overview
7.6.3 Huons Co Ltd Lysosomal Alpha Glucosidase Major Product Offerings
7.6.4 Huons Co Ltd Lysosomal Alpha Glucosidase Sales and Revenue in Global (2017-2022)
7.6.5 Huons Co Ltd Key News
7.7 JCR Pharmaceuticals Co Ltd
7.7.1 JCR Pharmaceuticals Co Ltd Corporate Summary
7.7.2 JCR Pharmaceuticals Co Ltd Business Overview
7.7.3 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Major Product Offerings
7.7.4 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales and Revenue in Global (2017-2022)
7.7.5 JCR Pharmaceuticals Co Ltd Key News
7.8 Oxyrane Belgium NV
7.8.1 Oxyrane Belgium NV Corporate Summary
7.8.2 Oxyrane Belgium NV Business Overview
7.8.3 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Major Product Offerings
7.8.4 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales and Revenue in Global (2017-2022)
7.8.5 Oxyrane Belgium NV Key News
7.9 Pharming Group NV
7.9.1 Pharming Group NV Corporate Summary
7.9.2 Pharming Group NV Business Overview
7.9.3 Pharming Group NV Lysosomal Alpha Glucosidase Major Product Offerings
7.9.4 Pharming Group NV Lysosomal Alpha Glucosidase Sales and Revenue in Global (2017-2022)
7.9.5 Pharming Group NV Key News
7.10 Sarepta Therapeutics Inc
7.10.1 Sarepta Therapeutics Inc Corporate Summary
7.10.2 Sarepta Therapeutics Inc Business Overview
7.10.3 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Major Product Offerings
7.10.4 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales and Revenue in Global (2017-2022)
7.10.5 Sarepta Therapeutics Inc Key News
8 Global Lysosomal Alpha Glucosidase Production Capacity, Analysis
8.1 Global Lysosomal Alpha Glucosidase Production Capacity, 2017-2028
8.2 Lysosomal Alpha Glucosidase Production Capacity of Key Manufacturers in Global Market
8.3 Global Lysosomal Alpha Glucosidase Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Lysosomal Alpha Glucosidase Supply Chain Analysis
10.1 Lysosomal Alpha Glucosidase Industry Value Chain
10.2 Lysosomal Alpha Glucosidase Upstream Market
10.3 Lysosomal Alpha Glucosidase Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lysosomal Alpha Glucosidase Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com